S&P 500

5.308,13

0,09%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Supergen, Inc. (MM) (SUPG)
Supergen, Inc. (MM) (SUPG) Notícias

SUPG

Supergen, Inc. (MM) (SUPG)

Supergen, Inc. (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SUPG

1 2 3 4 5 6 7 8 9 10 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
02/09/2011	07:00	Business Wire	SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference as Astex Pharmaceuticals, Inc. on September 12th	NASDAQ:SUPG	Supergen, Inc. (MM)
02/09/2011	07:00	Business Wire	SuperGen, Inc. to Change Name and Stock Ticker Symbol	NASDAQ:SUPG	Supergen, Inc. (MM)
09/08/2011	17:07	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:SUPG	Supergen, Inc. (MM)
03/08/2011	08:45	Business Wire	SuperGen Reports 2011 Second Quarter Financial Results	NASDAQ:SUPG	Supergen, Inc. (MM)
26/07/2011	15:20	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:SUPG	Supergen, Inc. (MM)
25/07/2011	17:05	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (S-8)	NASDAQ:SUPG	Supergen, Inc. (MM)
22/07/2011	20:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SUPG	Supergen, Inc. (MM)
22/07/2011	20:38	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SUPG	Supergen, Inc. (MM)
22/07/2011	07:00	Business Wire	SuperGen to Announce 2011 Second Quarter Financial Results on August 3, 2011	NASDAQ:SUPG	Supergen, Inc. (MM)
20/07/2011	13:30	Business Wire	SuperGen Completes Acquisition of Astex Therapeutics	NASDAQ:SUPG	Supergen, Inc. (MM)
13/07/2011	09:00	Business Wire	FDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia	NASDAQ:SUPG	Supergen, Inc. (MM)
28/06/2011	17:27	Business Wire	SuperGen President & CEO Elected to BIO Board of Directors	NASDAQ:SUPG	Supergen, Inc. (MM)
16/06/2011	19:00	Business Wire	SuperGen Stockholders Approve Stock Issuance In Connection with the Proposed Acquisition of Astex Therapeutics Limited	NASDAQ:SUPG	Supergen, Inc. (MM)
06/06/2011	15:50	PR Newswire (US)	SuperGen, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com	NASDAQ:SUPG	Supergen, Inc. (MM)
06/06/2011	13:00	Business Wire	Eisai & Janssen Announce the Presentation of DACOGEN® (decitabine) Data at ASCO from a Phase III Study in Patients with Acut...	NASDAQ:SUPG	Supergen, Inc. (MM)
31/05/2011	13:57	PR Newswire (US)	Public Company CEOs Present Live, Online at June 2nd RetailInvestorConferences.com Event	NASDAQ:SUPG	Supergen, Inc. (MM)
26/05/2011	16:00	PR Newswire (US)	SuperGen, Inc. to Present Live, Online at RetailInvestorConferences.com on June 2nd	NASDAQ:SUPG	Supergen, Inc. (MM)
25/05/2011	17:56	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:SUPG	Supergen, Inc. (MM)
16/05/2011	09:00	Business Wire	SuperGen to Present at BioEquity Europe on May 23rd & 24th	NASDAQ:SUPG	Supergen, Inc. (MM)
10/05/2011	07:00	Business Wire	SuperGen to Present at Noble Financial Capital Markets Equity Conference on May 17th	NASDAQ:SUPG	Supergen, Inc. (MM)
02/05/2011	18:24	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)	NASDAQ:SUPG	Supergen, Inc. (MM)
27/04/2011	17:00	Business Wire	SuperGen Reports 2011 First Quarter Financial Results	NASDAQ:SUPG	Supergen, Inc. (MM)
22/04/2011	18:29	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (PREM14A)	NASDAQ:SUPG	Supergen, Inc. (MM)
20/04/2011	07:00	Business Wire	SuperGen to Announce 2011 First Quarter Financial Results on April 27, 2011	NASDAQ:SUPG	Supergen, Inc. (MM)
08/04/2011	07:00	Business Wire	SuperGen to Present at Future Leaders in the Biotech Industry on April 15th	NASDAQ:SUPG	Supergen, Inc. (MM)
06/04/2011	22:56	Business Wire	SuperGen and Astex Therapeutics Enter Definitive Merger Agreement	NASDAQ:SUPG	Supergen, Inc. (MM)
31/03/2011	07:00	Business Wire	SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011	NASDAQ:SUPG	Supergen, Inc. (MM)
31/03/2011	07:00	Business Wire	SuperGen PIM Kinase Presentations at AACR	NASDAQ:SUPG	Supergen, Inc. (MM)
09/03/2011	18:13	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:SUPG	Supergen, Inc. (MM)
08/03/2011	08:00	Business Wire	SuperGen to Present at ROTH Annual OC Growth Stock Conference on March 14th	NASDAQ:SUPG	Supergen, Inc. (MM)